| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.007 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |